KDM3A is upregulated in several cancers and coordinates with multiple oncogenic transcription factors (e.g., c-Myc, androgen receptor, estrogen receptor, β-catenin, hypoxia-inducible factor-1α, etc.)to promote cancer progression and therapeutic resistance [9]. This evidence concerns the gene AR and cancer.